Literature DB >> 12788511

Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination.

R Lalonde1, T L Lewis, C Strazielle, H Kim, K Fukuchi.   

Abstract

The functional consequences of the betaAPP transgene with the Swedish mutation in mice were assessed in tests of exploratory activity and motor coordination. The betaAPP(695)SWE (Tg2576) transgenic mice are characterized by Abeta plaque formation in the neocortex and hippocampus. By comparison to non-transgenic mice controlled for age and gender, 17-month-old betaAPP(695)SWE transgenic mice displayed impaired spontaneous alternation, increased activity levels in the peripheral part of the open-field, and reduced anxiety in the elevated plus-maze. These results are similar to the loss of inhibitory control observed in some patients with Alzheimer's disease. These measures may be added to cognitive dysfunctions as testing ground for Abeta vaccination and other attempts at experimental therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788511     DOI: 10.1016/s0006-8993(03)02694-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease.

Authors:  Mark E Bardgett; Natasha N Davis; Patrick J Schultheis; Molly S Griffith
Journal:  Neurobiol Learn Mem       Date:  2010-11-10       Impact factor: 2.877

3.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

4.  Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the AppNL-G-F Mouse Model of Alzheimer's Disease.

Authors:  Mona Sohrabi; Heidi L Pecoraro; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 5.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

Review 6.  Rodent models for Alzheimer's disease drug discovery.

Authors:  Daniela Puzzo; Walter Gulisano; Agostino Palmeri; Ottavio Arancio
Journal:  Expert Opin Drug Discov       Date:  2015-04-30       Impact factor: 6.098

7.  Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease.

Authors:  Sara Duarte-Silva; Andreia Neves-Carvalho; Carina Soares-Cunha; Andreia Teixeira-Castro; Pedro Oliveira; Anabela Silva-Fernandes; Patrícia Maciel
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

8.  Central CRF system perturbation in an Alzheimer's disease knockin mouse model.

Authors:  Qinxi Guo; Hui Zheng; Nicholas John Justice
Journal:  Neurobiol Aging       Date:  2012-02-14       Impact factor: 4.673

9.  Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome.

Authors:  Qing Chang; Paul E Gold
Journal:  Neurobiol Learn Mem       Date:  2007-07-20       Impact factor: 2.877

10.  COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo.

Authors:  Ying Tong; Ying Xu; Kimberly Scearce-Levie; Louis J Ptácek; Ying-Hui Fu
Journal:  Neurogenetics       Date:  2009-06-23       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.